[Back to Overwiew]  [IACM Homepage]

IACM-Bulletin of 25 March 2020

IACM: Statement of the Board on current corona virus pandemic and the use of cannabinoids

Several laboratory studies suggest that cannabinoids may have antiviral and antibacterial effects. We have reported on this repeatedly in the IACM-Bulletin.

However, there is no evidence that individual cannabinoids -- such as CBD, CBG or THC -- or cannabis preparations protect against infection with the SARS-CoV2 virus or could be used to treat Covid-19, the disease produced by this virus.

Also, there is no evidence that the use of cannabinoids could increase the risk of viral infection.

Please do not pass on false information that is circulating on the Internet. Help contain the spread of the virus by following government and health authority guidelines.

Let us be in solidarity during this time, especially with those who are particularly at risk from such an infection.

Take care of yourself and others!

On behalf of the IACM Board of Directors

Dr. Kirsten Müller-Vahl (1st Chairwomen)
Dr. Franjo Grotenhermen (Executive Director)

A glimpse @ the past

One year ago

Two years ago

[Back to Overwiew]  [IACM Homepage]

up

Online Events 2020

Please find all information of IACM Online Events including free videos of the webinars here.

Conference 2022

The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.